To further assess the diagnostic potential of APLP1+ EVs for brain diseases, we evaluated their expression in the blood of patients with glioblastoma multiforme (GBM) exhibiting EGFR and EGFRviii expression (Fig. 7A). Here, APLP1 is linked to brain disorder.